SAM
GOSS icon

Silvercrest Asset Management’s Gossamer Bio GOSS Stock Holding History

Silvercrest Asset Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-26,158
Closed -$32.2K – 844
2025
Q2 		$32.2K Hold
26,158
– – ﹤0.01% 834
2025
Q1 		$28.8K Hold
26,158
– – ﹤0.01% 837
2024
Q4 		$23.7K Hold
26,158
– – ﹤0.01% 821
2024
Q3 		$25.8K Buy
26,158
+6,250
+31% +$6.01K ﹤0.01% 797
2024
Q2 		$17.9K Hold
19,908
– – ﹤0.01% 895
2024
Q1 		$23.5K Hold
19,908
– – ﹤0.01% 882
2023
Q4 		$18.2K Hold
19,908
– – ﹤0.01% 833
2023
Q3 		$16.6K Hold
19,908
– – ﹤0.01% 825
2023
Q2 		$23.9K Buy
+19,908
New +$24.8K ﹤0.01% 816

Other funds holding GOSS

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Silvercrest Asset Management's GOSS Position: Q3 2025 in Review

Silvercrest Asset Management sold out of Gossamer Bio (GOSS) in Q3 2025, closing a stake of 26,158 shares — an estimated $32.2K sold.

Silvercrest Asset Management first reported a position in GOSS in Q2 2023 and held it in 9 quarters. The position peaked at $32.2K in Q2 2025. 164 funds tracked by Wall St. Rank hold GOSS as of Q3 2025.

  • Silvercrest Asset Management reported no remaining Gossamer Bio position as of Q3 2025 after selling out during the quarter.
  • Silvercrest Asset Management sold 26,158 Gossamer Bio shares in Q3 2025, an estimated $32.2K.
  • Silvercrest Asset Management first reported a position in Gossamer Bio in Q2 2023 and held it in 9 quarters.
  • Silvercrest Asset Management's Gossamer Bio position peaked at $32.2K in Q2 2025.
  • 164 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2025.

Based on Silvercrest Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.